According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$2.08. In 2024 the company made an earnings per share (EPS) of NZ-$8.30 a decrease over its 2023 EPS that were of NZ-$3.18.